Pioneering Possibility ^®

At Device Technologies, our Infection Prevention team is committed to protecting the health and safety of healthcare professionals and their patients across Australia. For more than 30 years, the team has helped advance infection prevention and control across the regions by introducing leading technologies and solutions for surgical decontamination, sterilisation, and medical device reprocessing, supporting healthcare facilities in maintaining high standards of safety and patient care. Bringing extensive specialist knowledge, our team proudly works alongside hospitals, healthcare professionals and central sterile services departments (CSSD) to understand their needs, challenges, and patient outcomes, allowing for effective, evidence-based infection prevention strategies, solutions, and ongoing support.

Global sterilisation specialist Matachana will appoint Device Technologies as its exclusive distributor in Australia and New Zealand, effective 1 January 2027.

Australia’s National Lung Cancer Screening Program represents a significant milestone. From a thoracic surgeon’s perspective, what impact is early detection having on patient care and treatment pathways?

Device Technologies has announced that it has signed an exclusive distribution agreement with Johnson & Johnson MedTech to supply